Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ann Phys Rehabil Med ; 63(2): 159-166, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31276838

RESUMEN

Learning and memory impairments are common in individuals with multiple sclerosis (MS) and have pervasive effects on everyday life functioning. Hence, memory and learning have received particular attention in the cognitive rehabilitation literature in MS. The effectiveness of memory rehabilitation on memory performance is supported by several studies, but the generalisability of the benefits to daily life and memory for real-life events has rarely been examined. Recently, a new line of research focusing on memory for personal life events (i.e., autobiographical memory) has emerged in the MS literature. This approach is complementary to classical learning and memory paradigms and also allows for approaching memory in a broader context, one that considers memory as the ability to remember past episodes and imagine events that may occur in one's personal future (i.e. future thinking). This review provides an overview of the findings in this line of work. The first part summarises current evidence regarding the cognitive and neural mechanisms underlying autobiographical memory and future thinking impairments in MS. It points out that these domains are frequently and early impaired in individuals with MS because of an executive/frontal-related deficit. Individuals with MS are generally aware of these deficits and their negative impact on everyday life, so the development of strategies to alleviate such deficits seems of paramount importance. Thus, in the second part, I present the main outcomes of a cognitive intervention developed by our research group, which has been specifically designed to alleviate autobiographical memory and future thinking impairments in individuals with MS. The implications of these findings for neuropsychological care and well-being of individuals with MS are discussed in the final section, with an emphasis on the functional role of autobiographical memory and future thinking in various domains, including personal identity.


Asunto(s)
Trastornos de la Memoria/etiología , Memoria Episódica , Esclerosis Múltiple/psicología , Corteza Cerebral/fisiopatología , Función Ejecutiva , Femenino , Predicción , Humanos , Discapacidades para el Aprendizaje/etiología , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/rehabilitación , Masculino , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/rehabilitación , Esclerosis Múltiple/complicaciones , Neuroimagen , Pruebas Neuropsicológicas , Investigación Cualitativa , Índice de Severidad de la Enfermedad , Pensamiento
2.
Toxicol Appl Pharmacol ; 354: 153-175, 2018 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-29524501

RESUMEN

The Adverse Outcome Pathways (AOPs) are designed to provide mechanistic understanding of complex biological systems and pathways of toxicity that result in adverse outcomes (AOs) relevant to regulatory endpoints. AOP concept captures in a structured way the causal relationships resulting from initial chemical interaction with biological target(s) (molecular initiating event) to an AO manifested in individual organisms and/or populations through a sequential series of key events (KEs), which are cellular, anatomical and/or functional changes in biological processes. An AOP provides the mechanistic detail required to support chemical safety assessment, the development of alternative methods and the implementation of an integrated testing strategy. An example of the AOP relevant to developmental neurotoxicity (DNT) is described here following the requirements of information defined by the OECD Users' Handbook Supplement to the Guidance Document for developing and assessing AOPs. In this AOP, the binding of an antagonist to glutamate receptor N-methyl-d-aspartate (NMDAR) receptor is defined as MIE. This MIE triggers a cascade of cellular KEs including reduction of intracellular calcium levels, reduction of brain derived neurotrophic factor release, neuronal cell death, decreased glutamate presynaptic release and aberrant dendritic morphology. At organ level, the above mentioned KEs lead to decreased synaptogenesis and decreased neuronal network formation and function causing learning and memory deficit at organism level, which is defined as the AO. There are in vitro, in vivo and epidemiological data that support the described KEs and their causative relationships rendering this AOP relevant to DNT evaluation in the context of regulatory purposes.


Asunto(s)
Rutas de Resultados Adversos , Encéfalo/efectos de los fármacos , Conducta Infantil/efectos de los fármacos , Desarrollo Infantil/efectos de los fármacos , Antagonistas de Aminoácidos Excitadores/toxicidad , Discapacidades para el Aprendizaje/inducido químicamente , Aprendizaje/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Síndromes de Neurotoxicidad/etiología , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Adolescente , Adulto , Factores de Edad , Animales , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Discapacidades para el Aprendizaje/metabolismo , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/psicología , Memoria/efectos de los fármacos , Trastornos de la Memoria/metabolismo , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/psicología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/patología , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/fisiopatología , Síndromes de Neurotoxicidad/psicología , Receptores de N-Metil-D-Aspartato/metabolismo , Medición de Riesgo
5.
Brain Topogr ; 29(3): 459-76, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26671710

RESUMEN

Detecting and discriminating subtle and rapid sound changes in the speech environment is a fundamental prerequisite of language processing, and deficits in this ability have frequently been observed in individuals with language-learning impairments (LLI). One approach to studying associations between dysfunctional auditory dynamics and LLI, is to implement a training protocol tapping into this potential while quantifying pre- and post-intervention status. Event-related potentials (ERPs) are highly sensitive to the brain correlates of these dynamic changes and are therefore ideally suited for examining hypotheses regarding dysfunctional auditory processes. In this study, ERP measurements to rapid tone sequences (standard and deviant tone pairs) along with behavioral language testing were performed in 6- to 9-year-old LLI children (n = 21) before and after audiovisual training. A non-treatment group of children with typical language development (n = 12) was also assessed twice at a comparable time interval. The results indicated that the LLI group exhibited considerable gains on standardized measures of language. In terms of ERPs, we found evidence of changes in the LLI group specifically at the level of the P2 component, later than 250 ms after the onset of the second stimulus in the deviant tone pair. These changes suggested enhanced discrimination of deviant from standard tone sequences in widespread cortices, in LLI children after training.


Asunto(s)
Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/terapia , Aprendizaje/fisiología , Percepción del Habla/fisiología , Estimulación Acústica/métodos , Recursos Audiovisuales , Percepción Auditiva/fisiología , Encéfalo/fisiología , Corteza Cerebral/fisiología , Niño , Electroencefalografía , Potenciales Evocados/fisiología , Potenciales Evocados Auditivos , Femenino , Humanos , Lenguaje , Pruebas del Lenguaje , Masculino , Percepción de la Altura Tonal/fisiología
6.
Neuroscience ; 290: 485-91, 2015 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-25662510

RESUMEN

Studies demonstrated that chronic high-dose homocysteine administration induced learning and memory impairment in animals. Atractylenolide III (Aen-III), a neuroprotective constituent of Atractylodis macrocephalae Koidz, was isolated in our previous study. In this study, we investigated potential benefits of Aen-III in preventing learning and memory impairment following chronic high-dose homocysteine administration in rats. Results showed that administration of Aen-III significantly ameliorated learning and memory impairment induced by chronic high-dose homocysteine administration in rats, decreased homocysteine-induced reactive oxygen species (ROS) formation and restored homocysteine-induced decrease of phosphorylated protein kinase C expression level. Moreover, Aen-III protected primary cultured neurons from apoptotic death induced by homocysteine treatment. This study provides the first evidence for the neuroprotective effect of Aen-III in preventing learning and impairment induced by chronic administration of homocysteine. Aen-III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.


Asunto(s)
Lactonas/farmacología , Discapacidades para el Aprendizaje/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Sesquiterpenos/farmacología , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Células Cultivadas , Hipocampo/efectos de los fármacos , Hipocampo/fisiopatología , Homocisteína , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/fisiopatología , Neuronas/efectos de los fármacos , Neuronas/fisiología , Proteína Quinasa C/metabolismo , Distribución Aleatoria , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Memoria Espacial/efectos de los fármacos
7.
CNS Neurosci Ther ; 21(3): 280-8, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25601434

RESUMEN

AIMS: Compound IMM-H004 (7-hydroxy-5-methoxy-4-methyl-3-[4-methylpiperazin-1-yl]-2H-chromen-2-one) is a new synthetic derivative of coumarin, and previous studies showed that it exhibited antioxidant and neuroprotective roles in focal cerebral ischemia. However, we know little about the compound's function in transient global ischemia. This study is to investigate whether compound IMM-H004 can protect against transient global ischemic injury. METHODS: Four-vessel occlusion (4VO) rat model was induced for a 20-min occlusion and different times of reperfusion to mimic transient global cerebral ischemia. IMM-H004 (3, 6, 9 mg/kg) or Edaravone (6 mg/kg) was administered after 30 min of reperfusion. Morris water maze tests were used to estimate the ability of spatial learning and memory. Nissl staining, TUNEL assay and Immunoblot for Bax/Bcl-2 and activated caspase-3 were used to detect hippocampal neuron injury. Immunoblot for PSD-95 and synapsin 1, and electron microscopy were used to observe synaptic function. RESULTS: Compared with vehicle group, IMM-H004 significantly improved the spatial learning performance and exhibited less CA1 neurons loss. The expressions of Bax/Bcl-2 and activated caspase-3 were decreased. IMM-H004 also ameliorated synaptic structure, decreased PSD-95 and increased synapsin 1 expression. CONCLUSION: These findings suggested that IMM-H004 exerted neuroprotective role in global ischemia by reducing apoptosis and maintaining the integrity of synaptic structure.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Región CA1 Hipocampal/efectos de los fármacos , Cumarinas/farmacología , Discapacidades para el Aprendizaje/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Nootrópicos/farmacología , Animales , Antipirina/análogos & derivados , Antipirina/farmacología , Isquemia Encefálica/patología , Isquemia Encefálica/fisiopatología , Región CA1 Hipocampal/patología , Región CA1 Hipocampal/fisiopatología , Caspasa 3/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Modelos Animales de Enfermedad , Homólogo 4 de la Proteína Discs Large , Evaluación Preclínica de Medicamentos , Edaravona , Depuradores de Radicales Libres/farmacología , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Discapacidades para el Aprendizaje/patología , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Proteínas de la Membrana/metabolismo , Neuronas/efectos de los fármacos , Neuronas/patología , Neuronas/fisiología , Distribución Aleatoria , Ratas Sprague-Dawley , Memoria Espacial/efectos de los fármacos , Memoria Espacial/fisiología , Sinapsinas/metabolismo , Proteína X Asociada a bcl-2/metabolismo
8.
Child Adolesc Psychiatr Clin N Am ; 23(3): 465-86, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24975622

RESUMEN

Neurofeedback (NF) using surface electroencephalographic signals has been used to treat various child psychiatric disorders by providing patients with video/audio information about their brain's electrical activity in real-time. Research data are reviewed and clinical recommendations are made regarding NF treatment of youth with attention deficit/hyperactivity disorder, autism, learning disorders, and epilepsy. Most NF studies are limited by methodological issues, such as failure to use or test the validity of a full-blind or sham NF. The safety of NF treatment has not been thoroughly investigated in youth or adults, although clinical experience suggests reasonable safety.


Asunto(s)
Electroencefalografía/métodos , Neurorretroalimentación/métodos , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Trastorno por Déficit de Atención con Hiperactividad/terapia , Trastornos Generalizados del Desarrollo Infantil/fisiopatología , Trastornos Generalizados del Desarrollo Infantil/terapia , Epilepsia/fisiopatología , Epilepsia/terapia , Humanos , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/terapia , Resultado del Tratamiento
9.
Hear Res ; 313: 75-82, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24823662

RESUMEN

Neuronal firing synchronization is critical for recording auditory responses from the brainstem. Recent studies have shown that both click and/da/synthetic syllable (speech) stimuli perform well in evoking neuronal synchronization at the brainstem level. In the present study, brainstem responses to click and speech stimuli were compared between children with learning problems (LP) and those with normal learning (NL) abilities. The study included 49 children with LP and 34 children with NL. Auditory brainstem response (ABR) to 100-µs click stimulus and speech ABR (sABR) to/da/40-ms stimulus were tested in these children. Wave latencies III, V, and Vn and inter-peak latency (IPL) V-Vn in click ABR and wave latencies I, V, and A and IPL V-A in sABR were significantly longer in children with LP than children with NL. Except IPL of I-III, a significant positive correlation was observed between click ABR and sABR wave latencies and IPLs in children with NL; this correlation was weaker or not observed in children with LP. In this regard, the difference between correlation coefficients of wave latencies I, III, and V and IPLs I-V and V-Vn/V-A was significant in the two groups. Deficits in auditory processing timing in children with LP may have probably affected ABR for both click and speech stimuli. This finding emphasizes the possibility of shared connections between processing timing for speech and non-speech stimuli in auditory brainstem pathways. Weak or no correlation between click and speech ABR parameters in children with LP may have a clinical relevance and may be effectively used for objective diagnoses after confirming its sufficient sensitivity and specificity and demonstrating its acceptable validity with more scientific evidence.


Asunto(s)
Estimulación Acústica/métodos , Tronco Encefálico/fisiopatología , Potenciales Evocados Auditivos del Tronco Encefálico , Discapacidades para el Aprendizaje/fisiopatología , Factores de Edad , Audiometría del Habla , Estudios de Casos y Controles , Niño , Desarrollo Infantil , Electrocardiografía , Femenino , Humanos , Discapacidades para el Aprendizaje/diagnóstico , Discapacidades para el Aprendizaje/psicología , Masculino , Tiempo de Reacción , Factores de Tiempo
10.
J Commun Disord ; 45(6): 403-10, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22789822

RESUMEN

Auditory-based communication skills are developed at a young age and are maintained throughout our lives. However, some individuals - both young and old - encounter difficulties in achieving or maintaining communication proficiency. Biological signals arising from hearing sounds relate to real-life communication skills such as listening to speech in noisy environments and reading, pointing to an intersection between hearing and cognition. Musical experience, amplification, and software-based training can improve these biological signals. These findings of biological plasticity, in a variety of subject populations, relate to attention and auditory memory, and represent an integrated auditory system influenced by both sensation and cognition.


Asunto(s)
Percepción Auditiva/fisiología , Tronco Encefálico/fisiopatología , Instrucción por Computador , Potenciales Evocados Auditivos del Tronco Encefálico/fisiología , Audífonos , Musicoterapia/métodos , Enmascaramiento Perceptual/fisiología , Lectura , Programas Informáticos , Percepción del Habla/fisiología , Atención/fisiología , Vías Auditivas/fisiopatología , Corteza Cerebral/fisiopatología , Niño , Trastornos Generalizados del Desarrollo Infantil/fisiopatología , Trastornos Generalizados del Desarrollo Infantil/terapia , Dislexia/fisiopatología , Dislexia/terapia , Humanos , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/terapia , Memoria a Corto Plazo/fisiología , Fonética , Diseño de Prótesis , Espectrografía del Sonido
11.
Neuroscience ; 212: 93-103, 2012 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-22516014

RESUMEN

Previous research has demonstrated that diabetes induced learning and memory deficits. However, the mechanism of memory impairment induced by diabetes is poorly understood. Dietary fatty acids, especially polyunsaturated fatty acids (PUFA), have been shown to enhance learning and memory and prevent memory deficits in various experimental conditions. Sprague-Dawley rats were used in the present study to investigate the effect of fish oil supplementation on spatial learning and memory of streptozotocin (STZ)-induced diabetic rats with the Morris Water Maze. The excitability of CA1 pyramidal neurons and the related ionic currents was also examined. Diabetes impaired spatial learning and memory of rats. Diabetes decreased the sodium currents and increased the potassium currents, and further led to the reduction of excitability of CA1 pyramidal neurons, effects which may contribute to the behavioral deficits. Fish oil dietary supplementation decreased the transient currents and Kv4.2 expression in the hippocampus and partially improved learning performance of diabetic rats. The results of the present study suggested that sodium and potassium currents contributed to the inhibitory effect of diabetes on neuron excitability, further influencing learning and memory processing. Dietary fish oil may modulate the membrane excitability and is a possible strategy for preventing the impairments of diabetes on hippocampal function.


Asunto(s)
Encéfalo/efectos de los fármacos , Complicaciones de la Diabetes/dietoterapia , Ácidos Grasos Omega-3/farmacología , Discapacidades para el Aprendizaje/dietoterapia , Neuronas/efectos de los fármacos , Animales , Encéfalo/metabolismo , Encéfalo/fisiopatología , Complicaciones de la Diabetes/fisiopatología , Modelos Animales de Enfermedad , Ácidos Grasos Omega-3/metabolismo , Ácidos Grasos Omega-3/uso terapéutico , Discapacidades para el Aprendizaje/etiología , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Neuronas/metabolismo , Ratas , Ratas Sprague-Dawley , Resultado del Tratamiento
12.
Rev. Síndr. Down ; 28(111): 153-172, dic. 2011. ilus
Artículo en Español | IBECS | ID: ibc-102240

RESUMEN

El campo de la farmacología cognitiva para niños con discapacidad intelectual no existe todavía, pero el reciente desarrollo de la investigación que atiende a este objetivo parece prometedor. La investigación informada por la neurociencia, dirigida a conocer la base neurobiológica de la discapacidad intelectual en el síndrome de Down y otras patologías neurogenéticas está empezando a acumular una masa crítica investigadora con la atracción necesaria para avanzar hacia adelante. Agentes farmacológicos que apuntan a receptores GABA y glutamato y transportadores de dopamina ofrecen perspectivas como para iniciar ensayos clínicos. Las terapias basadas en células e intervenciones biológicas relacionadas con ellas se encuentran todavía en etapas muy inmaduras o ensayo preclínico, pero la infraestructura y los recursos que se necesitan para apoyar estos esfuerzos investigadores están lejos de conseguirse, lo que dificulta el progreso en este campo. La capacidad para convertir hallazgos fundamentales conseguidos desde la neurofarmacología y la neurociencia cognitiva en terapias fundamentadas en dichos hallazgos que mejoren las vidas de los niños con trisomía 21 sigue siendo, pues, todo un reto digno de afrontar (AU)


No disponible


Asunto(s)
Humanos , Síndrome de Down/tratamiento farmacológico , Trastornos del Conocimiento/fisiopatología , Neurofarmacología/tendencias , Neurociencias/tendencias , Discapacidades para el Aprendizaje/fisiopatología , Neurobiología/tendencias , Ensayos Clínicos como Asunto , Colinérgicos/uso terapéutico , Ácido Glutámico/uso terapéutico , Nootrópicos/uso terapéutico , Piracetam/uso terapéutico , Psicotrópicos/uso terapéutico , Terapia Biológica/tendencias
13.
Acta Physiol Hung ; 98(2): 221-30, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21616781

RESUMEN

Cognitive impairment occurs in diabetes mellitus. Glabridin as a major active flavonoids in Glycyrrhiza glabra (licorice) improves learning and memory in mice. In the present study, we investigated the effect of chronic treatment with glabridin (5, 25 and 50 mg/kg, p.o.) on cognitive function in control and streptozotocin (STZ)-induced diabetic rats.Animals were divided into untreated control, glabridin-treated control (5, 25 and 50 mg/kg), untreated diabetic and glabridin treated diabetic (5, 25 and 50 mg/kg) groups. Treatments were begun at the onset of hyperglycemia. Passive avoidance learning (PAL) and memory was assessed 30 days later. Diabetes caused cognition deficits in the PAL and memory paradigm. While oral glabridin administration (25 and 50 mg/kg) improved learning and memory in non-diabetic rats, it reversed learning and memory deficits of diabetic rats. Low dose glabridin (5 mg/kg) did not alter cognitive function in non-diabetic and diabetic groups. Glabridin treatment partially improved the reduced body weight and hyperglycemia of diabetic rats although the differences were not significant. The combination of antioxidant, neuroprotective and anticholinesterase properties of glabridin may all be responsible for the observed effects. These results show that glabridin prevented the deleterious effects of diabetes on learning and memory in rats. Further studies are warranted for clinical use of glabridin in the management of demented diabetic patients.


Asunto(s)
Diabetes Mellitus Experimental/psicología , Glycyrrhiza/metabolismo , Isoflavonas/metabolismo , Isoflavonas/uso terapéutico , Discapacidades para el Aprendizaje/prevención & control , Trastornos de la Memoria/prevención & control , Fenoles/metabolismo , Fenoles/uso terapéutico , Extractos Vegetales/uso terapéutico , Animales , Glucemia/fisiología , Peso Corporal/fisiología , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Trastornos del Conocimiento/prevención & control , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/complicaciones , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Discapacidades para el Aprendizaje/etiología , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Trastornos de la Memoria/etiología , Trastornos de la Memoria/fisiopatología , Ratas , Ratas Wistar , Estreptozocina
14.
Brain Res ; 1382: 147-54, 2011 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-21276426

RESUMEN

Ginsenoside Rb1 (Rb1) is known to improve learning and memory in hippocampus-dependent tasks. However, the cellular mechanism remains unknown. Cell genesis in hippocampus is involved in spatial learning and memory. In the present study, Rb1 was orally administrated to adult rats for 30days. The behavioral training tests indicated that Rb1 improved spatial cognitive performance of rats in Morris water maze (MWM). Furthermore, we investigated the effects of Rb1 on cell genesis in adult rats' hippocampus, using thymidine analog bromodeoxyuridine (BrdU) as a marker for dividing cells. It has been shown that hippocampal cell genesis can be influenced by several factors such as learning and exercise. In order to avoid the effects of the interfering factors, only the rats treated with Rb1 without training in MWM were used to investigate cell genesis in hippocampus. When BrdU was given to the rats 30days prior to being killed, it was shown that oral administration of Rb1 significantly increased cell survival in dentate gyrus and hippocampal subregion CA3. However, when BrdU was injected 2h prior to sacrifice, the results indicated that Rb1 had no significant influence on cell proliferation in the hippocampal subregions. Thus, an increase of cell survival in hippocampus stimulated by Rb1 may be one of the mechanisms by which ginseng facilitates spatial learning and memory. Our study also indicates that Rb1 may be developed as a therapeutic agent for patients with memory impairment.


Asunto(s)
Ginsenósidos/farmacología , Hipocampo/efectos de los fármacos , Discapacidades para el Aprendizaje/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Neurogénesis/efectos de los fármacos , Panax/química , Administración Oral , Animales , Cognición/efectos de los fármacos , Cognición/fisiología , Giro Dentado/efectos de los fármacos , Giro Dentado/fisiología , Ginsenósidos/uso terapéutico , Hipocampo/fisiología , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Memoria/efectos de los fármacos , Memoria/fisiología , Trastornos de la Memoria/fisiopatología , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/metabolismo , Neurogénesis/fisiología , Nootrópicos/farmacología , Nootrópicos/uso terapéutico , Fitoterapia/métodos , Ratas , Ratas Sprague-Dawley
15.
Neuroscience ; 177: 127-37, 2011 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-21195139

RESUMEN

Aging is thought to impair prefrontal cortical (PFC) structure-sensitive cognitive functions and flexibility, such as working memory and reversal learning. A traditional Japanese medicine, yokukansan (YKS), is frequently used to treat age-related neurodegenerative disorders such as Alzheimer's disease in Japan, but its pharmacological properties have not been elucidated. The present study was designed to examine whether YKS improves age-related cognitive deficits using aged rats. YKS was administered to 21-month-old rats for 3 months. The ability to learn initially a reward rule for a T-maze discrimination task (initial learning) was examined in young control (4-month-old), aged control (24-month-old) and YKS-treated aged (24-month-old) rats. Subsequently, working memory and reversal learning were examined in delayed alternation and reversal discrimination T-maze tasks, respectively. Locomotor activity was also measured in new environments. Although performance accuracy in the initial learning procedure did not differ among any experimental groups, accuracy in the delayed alternation task was significantly decreased in aged rats compared to young rats. Aged rats also showed significant decreases in accuracy in the reversal discrimination task. YKS treatment significantly ameliorated the age-related decreases in accuracy in the delayed alternation and reversal discrimination tasks. The ameliorative effects of YKS on impaired delayed alternation performance were reduced by intracranial infusions of a dopamine D1 receptor antagonist, SCH 23390, into the prelimbic cortical region of the PFC, and the YKS effects on impaired reversal learning were done by the infusions into the orbitofrontal cortex (OFC). Locomotor activity did not change in any experimental group. Thus, YKS ameliorated age-related impairments of working memory and reversal learning, which might be mediated by a dopaminergic mechanism in the PFC structure. These investigations provide information important for the treatment of brain dysfunctions in the elderly people.


Asunto(s)
Trastornos del Conocimiento/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Discapacidades para el Aprendizaje/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Nootrópicos/farmacología , Corteza Prefrontal/efectos de los fármacos , Aprendizaje Inverso/fisiología , Animales , Trastornos del Conocimiento/fisiopatología , Trastornos del Conocimiento/psicología , Modelos Animales de Enfermedad , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/psicología , Masculino , Medicina Kampo , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/psicología , Corteza Prefrontal/metabolismo , Corteza Prefrontal/fisiopatología , Ratas , Ratas Endogámicas F344 , Resultado del Tratamiento
16.
Int J Neural Syst ; 20(4): 279-92, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20726039

RESUMEN

Independent component analysis (ICA) does not follow the superposition rule. This motivates us to study a negative event-related potential - mismatch negativity (MMN) estimated by the single-trial based ICA (sICA) and averaged trace based ICA (aICA), respectively. To sICA, an optimal digital filter (ODF) was used to remove low-frequency noise. As a result, this study demonstrates that the performance of the sICA+ODF and aICA could be different. Moreover, MMN under sICA+ODF fits better with the theoretical expectation, i.e., larger deviant elicits larger MMN peak amplitude.


Asunto(s)
Potenciales Evocados Auditivos/fisiología , Potenciales Evocados/fisiología , Estimulación Acústica , Adolescente , Algoritmos , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Niño , Electroencefalografía , Humanos , Discapacidades para el Aprendizaje/fisiopatología
17.
Synapse ; 64(10): 773-85, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20698032

RESUMEN

Methamphetamine (MA) is widely abused and implicated in residual cognitive deficits. In rats, increases in plasma corticosterone and egocentric learning deficits are observed after a 1-day binge regimen of MA (10 mg/kg x 4 at 2-h intervals). The purpose of this experiment was to determine if adrenal inactivation during and following MA exposure would attenuate the egocentric learning deficits in the Cincinnati water maze (CWM). In the first experiment, the effects of adrenalectomy (ADX) or sham surgery (SHAM) on MA-induced neurotoxicity at 72 h were determined. SHAM-MA animals showed typical patterns of hyperthermia, whereas ADX-MA animals were normothermic. Both SHAM-MA- and ADX-MA-treated animals showed increased neostriatal glial fibrillary acidic protein and decreased monoamines in the neostriatum, hippocampus, and entorhinal cortex. In the second experiment, SHAM-MA- and ADX-MA-treated groups showed equivalently impaired CWM performance 2 weeks post-treatment (increased latencies, errors, and start returns) compared to SHAM-saline (SAL) and ADX-SAL groups with no effects on novel object recognition, elevated zero maze, or acoustic startle/prepulse inhibition. Post-testing, monoamine levels remained decreased in both MA-treated groups in all three brain regions, but were not as large as those observed at 72-h post-treatment. The data demonstrate that MA-induced learning deficits can be dissociated from drug-induced increases in plasma corticosterone or hyperthermia, but co-occur with dopamine and serotonin reductions.


Asunto(s)
Monoaminas Biogénicas/metabolismo , Estimulantes del Sistema Nervioso Central/efectos adversos , Hipertermia Inducida , Discapacidades para el Aprendizaje/inducido químicamente , Metanfetamina/efectos adversos , Estimulación Acústica/métodos , Adrenalectomía/métodos , Animales , Conducta Animal/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Corticosterona/sangre , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/metabolismo , Discapacidades para el Aprendizaje/sangre , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Inhibición Neural/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Conducta Estereotipada/efectos de los fármacos
18.
J Abnorm Child Psychol ; 38(7): 961-9, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20467805

RESUMEN

Attention-deficit/hyperactivity Disorder (ADHD) and obsessive-compulsive disorder (OCD) have both been linked to dysfunction in the cortico-striato-thalamo-cortical circuitry (CSTCC). However, the exact nature of neurocognitive deficits remains to be investigated in both disorders. We applied two neuropsychological tasks that tap into different functions associated with the CSTCC, namely a serial reaction time (SRT) task, developed to assess implicit sequence learning, and a delay aversion (DA) task in order to assess abnormal motivational processes. The performance data of boys with ADHD (n=20), OCD (n=20) and healthy controls (n=25), all aged 10-18 years, were compared. Subjects with ADHD less frequently chose the larger, more delayed reward compared to those with OCD and controls, while subjects with OCD showed impaired implicit learning. In contrast, the ADHD group was unimpaired in their implicit learning behavior and the OCD group was not characterized by a DA style. Within the OCD-group, severity of obsessions was associated with implicit learning deficits and impulsive symptoms with DA in the ADHD-group. This double dissociation highlights the distinct cognitive dysfunctions associated with ADHD and OCD and might possibly point to different neural abnormalities in both disorders.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastornos del Conocimiento/diagnóstico , Pruebas Neuropsicológicas/estadística & datos numéricos , Trastorno Obsesivo Compulsivo/diagnóstico , Adolescente , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Trastorno por Déficit de Atención con Hiperactividad/psicología , Corteza Cerebral/fisiopatología , Niño , Conducta de Elección/fisiología , Trastornos del Conocimiento/fisiopatología , Trastornos del Conocimiento/psicología , Cuerpo Estriado/fisiopatología , Humanos , Conducta Impulsiva/diagnóstico , Conducta Impulsiva/fisiopatología , Conducta Impulsiva/psicología , Discapacidades para el Aprendizaje/diagnóstico , Discapacidades para el Aprendizaje/fisiopatología , Discapacidades para el Aprendizaje/psicología , Masculino , Motivación/fisiología , Red Nerviosa/fisiopatología , Trastorno Obsesivo Compulsivo/fisiopatología , Trastorno Obsesivo Compulsivo/psicología , Psicometría , Recompensa , Tálamo/fisiopatología
19.
Neurosci Lett ; 478(3): 150-5, 2010 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-20457216

RESUMEN

High-sustained positive acceleration (+Gz) exposures might lead to impairment in cognitive function. Our previous studies have shown that electroacupuncture (EA) pretreatment can attenuate transient focal cerebral ischemic injury in the rats. In this study we aimed to investigate whether EA pretreatment could ameliorate the impairment of learning and memory induced by a sustained +Gz exposure. Using the centrifuge model, rats of experimental groups were exposed to +10 Gz for 5 min. Morris water maze was used for assessing the cognitive ability, and the apoptotic hippocampal CA1 pyramidal neuronal cells were evaluated by caspase-3 activity and TUNEL staining. Our results showed that +Gz exposure significantly caused pyramidal neuronal damage, increased neuronal apoptosis and caspase-3 activity in hippocampal CA1 region, as well as resulted in an impairment of spatial learning and memory, as compared to the sham group animals. Furthermore, the EA pretreatment significantly attenuated the neuronal apoptosis, preserved neuronal morphology and inhibited the caspase-3 activity in hippocampal CA1 region resulted from +Gz exposure. The EA pretreatment also ameliorated the learning and memory function in rats exposed to +Gz. These findings indicate that EA pretreatment provides a novel method to prevent the cognitive damage caused by +Gz, which could significantly protect neuronal damage and impairment of learning and memory.


Asunto(s)
Apoptosis/fisiología , Electroacupuntura/métodos , Hipocampo/fisiopatología , Hipergravedad/efectos adversos , Discapacidades para el Aprendizaje/terapia , Trastornos de la Memoria/terapia , Animales , Región CA1 Hipocampal/patología , Región CA1 Hipocampal/fisiopatología , Caspasa 3/metabolismo , Centrifugación , Hipocampo/patología , Discapacidades para el Aprendizaje/etiología , Discapacidades para el Aprendizaje/fisiopatología , Masculino , Aprendizaje por Laberinto/fisiología , Trastornos de la Memoria/etiología , Trastornos de la Memoria/fisiopatología , Neuronas/patología , Neuronas/fisiología , Pruebas Neuropsicológicas , Células Piramidales/patología , Células Piramidales/fisiopatología , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
20.
J Neurosci ; 30(8): 2918-23, 2010 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-20181589

RESUMEN

Many psychiatric and neurological disorders present persistent neuroanatomical abnormalities in multiple brain regions that may reflect a common origin for a developmental disturbance. In mammals, many of the local GABAergic inhibitory interneurons arise from a single subcortical source. Perturbations in the ontogeny of the GABAergic interneurons may be reflected in the adult by interneuron deficits in both frontal cerebral cortical and striatal regions. Disrupted GABAergic circuitry has been reported in patients with schizophrenia and frontal lobe epilepsy and may contribute to their associated impairments in behavioral flexibility. The present study demonstrates that one type of behavioral flexibility, reversal learning, is dependent upon proper numbers of GABAergic interneurons. Mice with abnormal interneuron ontogeny have reduced numbers of parvalbumin-expressing GABAergic local interneurons in the orbitofrontal cortical and striatal regions and impaired reversal leaning. Using a genetic approach, both the anatomical and functional deficiencies are restored with exogenous postnatal growth factor supplementation. These results show that GABAergic local circuitry is critical for modulating behavioral flexibility and that birth defects can be corrected by replenishing crucial growth factors.


Asunto(s)
Astrocitos/metabolismo , Factor de Crecimiento de Hepatocito/metabolismo , Interneuronas/metabolismo , Discapacidades para el Aprendizaje/metabolismo , Prosencéfalo/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Animales , Astrocitos/efectos de los fármacos , Biomarcadores/análisis , Biomarcadores/metabolismo , Cuerpo Estriado/anomalías , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Factor de Crecimiento de Hepatocito/genética , Factor de Crecimiento de Hepatocito/farmacología , Inmunohistoquímica , Interneuronas/efectos de los fármacos , Discapacidades para el Aprendizaje/tratamiento farmacológico , Discapacidades para el Aprendizaje/fisiopatología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Malformaciones del Sistema Nervioso/complicaciones , Malformaciones del Sistema Nervioso/metabolismo , Malformaciones del Sistema Nervioso/fisiopatología , Vías Nerviosas/anomalías , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Pruebas Neuropsicológicas , Parvalbúminas/análisis , Parvalbúminas/metabolismo , Corteza Prefrontal/anomalías , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Prosencéfalo/anomalías , Prosencéfalo/efectos de los fármacos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA